Aurora Cannabis Inc. (ACB)

5.57
0.38 6.50
NYSE : Process Industries
Prev Close 5.95
Open 5.75
Day Low/High 5.61 / 5.83
52 Wk Low/High 4.58 / 12.53
Volume 12.12M
Avg Volume 11.84M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 6.04B
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Aurora Cannabis And UFC® Launch Clinical Research On Use Of Hemp-Derived CBD Products By MMA Athletes

Aurora Cannabis And UFC® Launch Clinical Research On Use Of Hemp-Derived CBD Products By MMA Athletes

New studies to advance the science on CBD use and athlete health and wellness and to drive product development under new U.

Cutting a Position in Half

As promised, we continue to work our way out of Aurora Cannabis.

Stocks Under $10 Weekly Summary

As the momentum of earnings season rose last week, we made several trades including initiating a new position in Innovative Solutions and Support.

Updates on Actions Taken Wednesday

Several news items impact our thinking on how to proceed with Aurora Cannabis and Energy Recovery.

Aurora Cannabis Selected As Sole Winner In Italian Cannabis Tender

Aurora Cannabis Selected As Sole Winner In Italian Cannabis Tender

Secures Two-Year Contract to Continue to Supply Italy with high-quality medical cannabis  NYSE: ACB  TSX:ACB  EDMONTON, July 18, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Taking Some Profits in 2 Names

We will take advantage of victories in Aurora Cannabis and Energy Recovery.

Ladenburg Analysts Spark Coverage of Cannabis Stocks Canopy, Aurora and Tilray

Ladenburg Analysts Spark Coverage of Cannabis Stocks Canopy, Aurora and Tilray

Ladenburg Thalmann initiated coverage of the cannabis sector, with preference for companies focused on long-term value creation.

Stocks Under $10 Weekly Summary

We added to one position last week as as the small-cap heavy Russell 2000 dipped.

Aurora Cannabis Obtains Two Licences For Outdoor Growing Operations

Aurora Cannabis Obtains Two Licences For Outdoor Growing Operations

New Outdoor research sites in Quebec and British Columbia to study best-in-class cultivation techniques and advance plant science NYSE: ACB   TSX:ACB  EDMONTON, July 15, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Cannabis Stocks Get Crushed: What We’re Going to Do

We have become less enchanted with the industry and Aurora Cannabis for some time and have our eye on an exit.

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023

Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.

Bank of America, Ford, Nio, Aurora Cannabis: 'Mad Money' Lightning Round

Bank of America, Ford, Nio, Aurora Cannabis: 'Mad Money' Lightning Round

Jim Cramer weighs in on Bank of America, Ford, Nio, Aurora Cannabis, Brookfield Renewable Partners and more.

Investors Flock to Tech: Cramer's 'Mad Money' Recap (Tuesday 7/9/19)

Investors Flock to Tech: Cramer's 'Mad Money' Recap (Tuesday 7/9/19)

Jim Cramer says the important thing is recognizing the slowdown exists and knowing how to deal with it.

Stocks Under $10 Weekly Summary

We added to one position and initiated another during a shortened holiday week.

Canopy Growth Turmoil and Why It Matters to Us

Aurora Cannabis is currently the portfolio's second best performer.

Stocks Under $10 Weekly Summary

We initiated a new position and added to a couple of others as we closed the books on the second quarter.

5 Cannabis ETFs to Fire Up Your Portfolio

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

Stocks Under $10 Weekly Summary

Last week we started two new positions, trimmed a winner and exited another name as the markets moved higher across the board.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?

This Is Canopy Growth's Must-Hold Support Level

This Is Canopy Growth's Must-Hold Support Level

Canopy Growth stock is taking a beating on Friday after the company disappointed investors with its quarterly results. Here's the must-hold support level for the stock now.

Reducing a Winner

We’ll trim our position in Aurora Cannabis in order to protect some gains.

Aurora Cannabis Prepared For Expansion Of Canada's Cannabis Market

Aurora Cannabis Prepared For Expansion Of Canada's Cannabis Market

Efficient distribution, new partnerships and a broad range of high-margin products  to be launched in major consumer markets NYSE: ACB   TSX:ACB       EDMONTON, June 21, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Canopy Growth Slips as Production, Margins Disappoint

Canopy Growth Slips as Production, Margins Disappoint

While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.

Stocks Under $10 Weekly Summary

With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.

Young Folks Are High on a Current Name, and We Plug Another Into the Bullpen

An investing app indicates Aurora Cannabis is popular with young investors, while we also intend to monitor alternative energy firm Plug Power.

Stocks Under $10 Weekly Summary

With the market rebounding, the majority of our positions rose week over week.

Tilray Is Tough to Trade as It Breaks Out of a Nasty Downtrend

Tilray Is Tough to Trade as It Breaks Out of a Nasty Downtrend

Tilray is erupting higher and breaking over downtrend resistance. It's been a long time coming for this troubled cannabis stock.

Cannabis Virtual Investor Conference Presentations Now Available For On-Demand Viewing

Cannabis Virtual Investor Conference Presentations Now Available For On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Bank of America lifts its price target on Cronos to $20 from $13.

Stocks Under $10 Weekly Summary

During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.

TheStreet Quant Rating: C- (Hold)